beta

TIG

TiGenix

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

TiGenix NV is engaged in developing and commercializing novel therapeutics from its proprietary technology platforms of allogeneic, or donor derived, stem cells.

Market Cap: 252 Billion

Primary Exchange: Nasdaq Global Select

Website: http://www.tigenix.com

Shares Outstanding: 5.91 Billion

Float: 5.91 Billion

Dividend: 0.0 (0.0%)

Beta: 8.389838

Sector: Healthcare

Industry: Biotechnology

Ethical Flags

Longest drawdown: 68 trading days

From: 2018-03-26 To: 2018-07-16

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud